Literature DB >> 2708973

Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient.

S H Kennedy1, S Tighe, G McVey, G M Brown.   

Abstract

Low melatonin and elevated cortisol levels have typically been reported during depression. The evidence that the converse is true during mania has been less well documented. In a single case design, repeated measures of nocturnal melatonin and cortisol were taken during mania, depression, and euthymia. Elevated levels of melatonin during mania and elevated cortisol levels during depression were the principal findings. There also did not appear to be any marked change in circadian rhythm of hormone output during the three clinical states. The implications of these findings in relation to noradrenergic dysfunction are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708973     DOI: 10.1097/00005053-198905000-00009

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  9 in total

Review 1.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 2.  Treating Circadian Rhythm Disruption in Bipolar Disorder.

Authors:  Alexandra K Gold; Gustavo Kinrys
Journal:  Curr Psychiatry Rep       Date:  2019-03-02       Impact factor: 5.285

Review 3.  Chronobiology of bipolar disorder: therapeutic implication.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

4.  Use of slow-release melatonin in treatment-resistant depression.

Authors:  E J Dalton; D Rotondi; R D Levitan; S H Kennedy; G M Brown
Journal:  J Psychiatry Neurosci       Date:  2000-01       Impact factor: 6.186

5.  Circadian secretion of cortisol in bipolar disorder.

Authors:  P Cervantes; S Gelber; F N Kin; V N Nair; G Schwartz
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

Review 6.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

7.  Altered expression of somatostatin signaling molecules and clock genes in the hippocampus of subjects with substance use disorder.

Authors:  Jake Valeri; Sinead M O'Donovan; Wei Wang; David Sinclair; Ratna Bollavarapu; Barbara Gisabella; Donna Platt; Craig Stockmeier; Harry Pantazopoulos
Journal:  Front Neurosci       Date:  2022-09-07       Impact factor: 5.152

8.  Heartbeat Complexity Modulation in Bipolar Disorder during Daytime and Nighttime.

Authors:  Mimma Nardelli; Antonio Lanata; Gilles Bertschy; Enzo Pasquale Scilingo; Gaetano Valenza
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

9.  Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling.

Authors:  Ji-Hyeon Lee; Jose Manuel Mellado-Gil; Young Jae Bahn; Sushrut M Pathy; Ying E Zhang; Sushil G Rane
Journal:  Cell Death Dis       Date:  2020-03-13       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.